US Patent Issued to EVER SUPREME BIO TECHNOLOGY on Dec. 30 for "Multispecific single domain antibodies chimeric antigen receptor and T-cell engager, nucleic acid, expressing cell thereof, pharmaceutical composition for treating cancer, and method for inhibiting proliferation of tumor cell" (Taiwanese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,519, issued on Dec. 30, was assigned to EVER SUPREME BIO TECHNOLOGY Co. LTD. (Taichung, Taiwan).

"Multispecific single domain antibodies chimeric antigen receptor and T-cell engager, nucleic acid, expressing cell thereof, pharmaceutical composition for treating cancer, and method for inhibiting proliferation of tumor cell" was invented by Der-Yang Cho (Taichung, Taiwan), Shao-Chih Chiu (Taichung, Taiwan), Shi-Wei Huang (Taichung, Taiwan), Chih-Ming Pan (Taichung, Taiwan), Chia-Ing Jan (Taichung, Taiwan), Mei-Chih Chen (Taichung, Taiwan), Yu-Chuan Lin (Taichung, Taiwan) and Chung-Chun Wu (Taichung, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office:...